E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/3/2006 in the Prospect News Biotech Daily.

Novare closes $16 million private placement of series D stock

By Lisa Kerner

Charlotte, N.C., Oct. 3 - Novare Surgical Systems Inc. closed of a $16 million private placement of its series D preferred stock.

Point Judith Capital and Tudor Investment Corp. led the financing round, joined by existing investors Thomas J. Fogarty, Channel Medical Partners, Canaan Partners, Asset Management and new investor Deerfield Partners.

Proceeds will be used to commercialize the company's RealHand high dexterity instruments for minimally invasive surgery such as gastric bypass, colectomy and hysterectomy.

Gina Raimondo, a partner at Point Judith Capital, has joined Novare's board of directors.

Novare is a medical device company located in Cupertino, Calif.

Issuer:Novare Surgical Systems Inc.
Issue:Series D preferred stock
Amount:$16 million
Investors:Point Judith Capital, Tudor Investment Corp. (co-led), Thomas J. Fogarty, Channel Medical Partners, Canaan Partners, Asset Management, Deerfield Partners
Announcement date:Oct. 3

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.